Aspen Semaglutide Canada Approval Clears Market Entry

Original Article by Nqobile Dludla | Reuters | 20 July 2026

Aspen Semaglutide Canada gains Health Canada approval, but API supply problems could delay the generic’s commercial launch.

AI Image | Chat-GPT

Aspen Semaglutide Canada gains Health Canada approval, but API supply problems could delay the generic’s commercial launch.

Subscription Required

You must be a subscriber to access all of this content.

Already a subscriber? Log in here

The NHLS is scrambling for new providers after funds for haematology pathology services ran dry, amid an R11.3bn provincial debt

Momentum Group has posted record earnings, with normalised headline earnings up 13% to R7.06bn – beating its R7bn Impact target a year early.

Sanlam has written its AfroCentric stake down to nil after the Bonitas exit but rules out a sale, betting it can revive the business.